{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:12:34Z","timestamp":1778634754103,"version":"3.51.4"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,8,21]]},"DOI":"10.18632\/oncotarget.3896","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T04:50:22Z","timestamp":1442292622000},"page":"20177-20189","source":"Crossref","is-referenced-by-count":13,"title":["The 14-3-3\u03c3\/GSK3\u03b2\/\u03b2-catenin\/ZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer"],"prefix":"10.18632","volume":"6","author":[{"given":"Cong","family":"Peng","sequence":"first","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Jia","sequence":"additional","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Guangzhou Institute of Snake Venom Research, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Yin","sequence":"additional","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingen","family":"Deng","sequence":"additional","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Luo","sequence":"additional","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengkun","family":"Wang","sequence":"additional","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guopei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"He","sequence":"additional","affiliation":[{"name":"Cancer Hospital and Cancer Research Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,5,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Forman","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2005.01.057","article-title":"Eastern Cooperative Oncology Group: Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group","volume":"23","author":"Forastiere","year":"2005","journal-title":"J Clin Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.oraloncology.2008.01.006","article-title":"Recent advances in Oral Oncology 2007: imaging, treatment and treatment outcomes","volume":"44","author":"Bagan","year":"2008","journal-title":"Oral Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.semradonc.2008.09.009","article-title":"Molecular target approaches in head and neck cancer: epidermal growth factor receptor and beyond","volume":"19","author":"Grandis","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/CCO.0b013e3282f9b575","article-title":"Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck","volume":"20","author":"Siu","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00432-010-0805-z","article-title":"Identification of proteins responsible for the multiple drug resistance in 5-fluorouracil-induced breast cancer cell using proteomics analysis","volume":"136","author":"He","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.febslet.2011.11.034","article-title":"14-3-3\u03c3 regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation","volume":"586","author":"He","year":"2012","journal-title":"FEBS Lett"},{"key":"8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0092-8674(00)80487-0","article-title":"The structural basis for 14-3-3: phosphopeptide binding specificity","volume":"91","author":"Cantley","year":"1997","journal-title":"Cell"},{"key":"9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1097-2765(00)80002-7","article-title":"14-3-3 sigma is a p53-regulated inhibitor of G2\/M progression","volume":"1","author":"Vogelstein","year":"1997","journal-title":"Mol Cell"},{"key":"10","doi-asserted-by":"crossref","first-page":"25647","DOI":"10.1074\/jbc.C100265200","article-title":"BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells","volume":"276","author":"Liu","year":"2001","journal-title":"J Biol Chem"},{"key":"11","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1128\/MCB.23.20.7096-7107.2003","article-title":"14-3-3 sigma positively regulates p53 and suppresses tumor growth","volume":"23","author":"Lee","year":"2003","journal-title":"Mol Cell Biol"},{"key":"12","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1073\/pnas.100566997","article-title":"High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer","volume":"97","author":"Sukumar","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"13","first-page":"4353","article-title":"Inactivation of the 14-3-3 sigma gene is associated with 5\u2032 CpG island hypermethylation in human cancers","volume":"60","author":"Imai","year":"2000","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1038\/sj.onc.1205303","article-title":"Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers","volume":"21","author":"Takahashi","year":"2002","journal-title":"Oncogene"},{"key":"15","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1158\/1078-0432.CCR-03-0510","article-title":"Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation","volume":"10","author":"Yaegashi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"16","first-page":"2072","article-title":"Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity","volume":"62","author":"Crook","year":"2002","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"23106","DOI":"10.1074\/jbc.M905616199","article-title":"Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression","volume":"275","author":"Lee","year":"2000","journal-title":"J Biol Chem"},{"key":"18","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1158\/0008-5472.CAN-05-3620","article-title":"DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B\/Akt activation and suppresses Akt-activated cancer","volume":"66","author":"Lee","year":"2006","journal-title":"Cancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/1535-7163.MCT-05-0395","article-title":"14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma","volume":"5","author":"Lee","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"20","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1111\/j.1742-4658.2010.07836.x","article-title":"Identification of carbonic anhydrase9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells","volume":"277","author":"He","year":"2010","journal-title":"FEBS J"},{"key":"21","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cell.2012.05.002","article-title":"Wnt signaling through inhibition of \u03b2-catenin degradation in an intact Axin1 complex","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.18632\/oncotarget.2169","article-title":"H-Prune through GSK-3\u03b2 interaction sustains canonical WNT\/\u03b2-catenin signaling enhancing cancer progression in NSCLC","volume":"5","author":"Zollo","year":"2014","journal-title":"Oncotarget"},{"key":"23","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.18632\/oncotarget.1993","article-title":"MACC1 promotes carcinogenesis of colorectal cancer via \u03b2-catenin signaling pathway","volume":"5","author":"Han","year":"2014","journal-title":"Oncotarget"},{"key":"24","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.18632\/oncotarget.2105","article-title":"GRP78 enhances the glutamine metabolism to support cell survival from glucose deficiency by modulating the \u03b2-catenin signaling","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"25","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.18632\/oncotarget.2104","article-title":"Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt\/\u03b2-catenin signalling in pancreatic adenocarcinoma","volume":"5","author":"Van Die","year":"2014","journal-title":"Oncotarget"},{"key":"26","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2010.10.032","article-title":"\u03b2-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells","volume":"18","author":"So","year":"2010","journal-title":"Cancer Cell"},{"key":"27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10555-008-9179-y","article-title":"E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer","volume":"28","author":"Brabletz","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"28","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/emmm.201302827","article-title":"The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance","volume":"5","author":"Steindler","year":"2013","journal-title":"EMBO Mol Med"},{"key":"29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ncb3013","article-title":"ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1","volume":"16","author":"Ma","year":"2014","journal-title":"Nat Cell Biol"},{"key":"30","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1016\/j.febslet.2005.07.026","article-title":"Defective binding of transcriptional repressor ZEB via DNA methylation contributes to increased constitutive levels of p73 in Fanconi anemia cells","volume":"579","author":"Fernandez-Luna","year":"2005","journal-title":"FEBS Lett"},{"key":"31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/gutjnl-2011-300060","article-title":"Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer","volume":"61","author":"Weiss","year":"2012","journal-title":"Gut"},{"key":"32","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.1073\/pnas.1108977108","article-title":"\u03b2-catenin\/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness","volume":"108","author":"Postigo","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"33","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ncb3050","article-title":"ASPP2 controls epithelial plasticity and inhibits metastasis through \u03b2-catenin-dependent regulation of ZEB1","volume":"16","author":"Lu","year":"2014","journal-title":"Nat Cell Biol"},{"key":"34","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1073\/pnas.100566997","article-title":"High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer","volume":"97","author":"Sukumar","year":"2000","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T09:20:30Z","timestamp":1599556830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,8]]},"references-count":34,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2015,8,21]]}},"alternative-id":["3896","26036631"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.3896","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,8]]}}}